Intravesical chemotherapy for superficial bladder cancer

Nature Clinical Practice Urology

Volumn 1, Issue 2, 2004, Pages 56-57

  Witjes, J Alfred ^a   Debruyne, Frans M J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; DOXORUBICIN; EPIRUBICIN; GEMCITABINE; IMMUNOSUPPRESSIVE AGENT; MITOMYCIN C; THIOTEPA; VALRUBICIN;

BLADDER CANCER; BLADDER IRRITATION; CANCER INCIDENCE; CANCER PATIENT; CANCER RECURRENCE; CARCINOMA IN SITU; CLINICAL TRIAL; CYSTOSCOPY; DIAGNOSTIC ACCURACY; EUROPEAN UNION; HIGH RISK PATIENT; HUMAN; HYPERTHERMIC THERAPY; MEDICAL SOCIETY; NETHERLANDS; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; URINE CYTOLOGY;

ADMINISTRATION, INTRAVESICAL; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 20444461134     PISSN: 17434270     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpuro0009     Document Type: Review

References (11)

1. Lotan Y and Roehrborn CG (2003) Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology 61: 109-118
2. Schmidbauer J et al. (2004) Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 171: 135-138
3. Jakse G et al. (2004) A second-look TUR in T1 transitional cell carcinoma: why? Eur Urol 45: 539-546
4. Oosterlinck W et al. (2002) Guidelines on bladder cancer. Eur Urol 41: 105-112
5. Sylvester RJ et al. (2004) A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171: 2186-2190
6. Pawinski A et al. (1996) A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. J Urol 156: 1934-1940
7. Sylvester RJ et al. (2002) Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168: 1964-1970
8. Witjes JA et al. (1998) Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer. J Urol 160: 1668-1671
9. Colombo R et al. (1998) Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors. J Urol 159: 783-787
10. Colombo R et al. (2003) Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 21: 4270-4276
11. Van Der Heijden AG et al. (2004) Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder. Eur Urol 46: 65-71